Top news of the week: 01.09.2020.
#lifesciences #biotechnology #biospace #pharmaceuticals #COVID19 #coronavirus #COVID #treatment #vaccine #pandemic
Companies And Industries
Biopharma Update on the Novel Coronavirus: August 31
#biospace #lifesciences #biotechnology #pharmaceuticals #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/134gskp7KN
OpenBiopharma Update on the Novel Coronavirus: August 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 31, 2020.
Working with the first tranche of a grant of up to £2.3 million ($3.0 million), Vaccitech plans to wrap up preclinical development of its asset and make enough doses to run a phase 1 trial that is expected to start next year. https://t.co/23SickwGsE
OpenBiotech behind AstraZeneca's COVID-19 vaccine advances next-gen prospect
Vaccitech has received U.K. government funding for a COVID-19 vaccine that it thinks can improve on first-generation prospects such as the AstraZeneca jab it helped develop.
Connect Biopharma adds $115M to the pot as it eyes rivalry with Dupixent https://t.co/1eKVv5pt1k https://t.co/xJ12M4rUFo
OpenConnect Biopharma adds $115M to the pot as it eyes rivalry with Dupixent
While Sanofi and Regeneron’s Dupixent racks up the sales, more and more biotechs want a piece of the action.
Join us for our webinar Biotech Votes 2020 on September 14. Hear an in-depth discussion on the political races that matter most, from the top-of-the-ticket, through the Senate and House, and down the ballot to pivotal state races. https://t.co/Yr219vUbSl
Open
Biopharma Update on the Novel Coronavirus: August 26
#biospace #lifesciences #biotechnology #pharmaceuticals #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/vwTSnld9f6
OpenBiopharma Update on the Novel Coronavirus: August 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 26, 2020.
Kinnate Biopharma Raises $98M in Series C Financing Round
#biospace #lifesciences #biotechnology #pharmaceuticals
https://t.co/bic3UtCUbn
OpenKinnate Biopharma Raises $98M in Series C Financing Round
New investors who joined the funding round include Viking Global Investors, Venrock Healthcare Capital Partners and Janus Henderson Investors.
RT @Nasdaq: Today, biotech pioneer @Amgen ($AMGN) joined the DJIA. Congrats on your addition as the 6th #NasdaqListed company on the 30-stock benchmark!
Learn more: https://t.co/E4fXHFjHk6 https://t.co/hval73ehq1
OpenAmgen Joins Dow Jones Industrial Average as the Benchmark Index Revamps to ‘Better Reflect’ the U.S. Economy
As of the opening bell on Monday, biotech pioneer Amgen joined the Dow Jones Industrial Average, making it the 6th Nasdaq-listed company to join the 30-stock benchmark.
RT @venture_center: Check out our upcoming BIG Awareness talks, in which our #mentors will share tips & pointers for writing a winning BIG proposal. @BIRAC_2012 Register:
Aug 29 event: https://t.co/aW9q2YthJk
Sep 1 event: https://t.co/HIN0joKSPP
Sep 2 event: https://t.co/DQiMqzzPO7
#pune #funding https://t.co/WW7iP3ghkn
OpenBiotechnology Ignition Grant (BIG) Scheme – BIRAC BIG-TALK
WEDNESDAY, 2nd SEPTEMBER 2020, 3:00 pm - 4: 30 pm